gender-affirming care

Peer-Reviewed Study Finds Puberty Blockers Associated with Improved Mental Health Outcomes for Transgender Youth

A large, peer-reviewed study published in JAMA Network Open found that transgender youths prescribed puberty blockers had significantly lower adjusted odds of diagnosed mood disorders and suicidal thoughts and behaviors than transgender youths who did not receive the medications, adding new evidence to a politically contentious area of pediatric medicine.

Bonta Leads Coalition against Trump DOJ Subpoena for Minors’ Gender Care Data

California Attorney General Rob Bonta, leading a coalition of 19 attorneys general, filed an amicus brief challenging the Trump administration’s efforts to obtain personal health information regarding minors who received gender-affirming care at Stanford Children’s Hospital. The brief contends such actions infringe upon states’ constitutional authority to regulate medical practice.

California Joins Multistate Brief Opposing DOJ Subpoena for Gender-Affirming Care Records

California Attorney General Rob Bonta joined a multistate amicus brief opposing the U.S. Department of Justice’s efforts to obtain patient information from New York University Langone Hospitals regarding gender-affirming care for minors. The brief asserts that the federal government’s actions constitute an infringement upon states’ authority to regulate medical practice.

Study Links Hormone Therapy to Reduced Runaway Risk for Transgender Adolescents

A study by Southern Oregon University and Rutgers University researchers found that transgender adolescents who received hormone replacement therapy (HRT) were less likely to run away from home. The analysis, based on data from the 2015 United States Transgender Survey, indicated a 2 percentage point reduction in the likelihood of running away, reinforcing arguments that gender-affirming care contributes to improved mental health outcomes for transgender youth.

States Challenge DOJ Effort Targeting Transgender Health Care for Adolescents

California Attorney General Rob Bonta, joined by attorneys general from 21 states and jurisdictions, filed an amicus brief opposing a U.S. Department of Justice subpoena issued to Rhode Island Hospital. The brief argued the federal action seeks to undermine transgender health care for adolescents and represents a novel, unreasonable interpretation of the Federal Food, Drug, and Cosmetic Act (FDCA) with broad implications.